A5074517173- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Rheumatoid Arthritis Research and Therapies
- Systemic Sclerosis and Related Diseases
- Systemic Lupus Erythematosus Research
- Long-Term Effects of COVID-19
- Parkinson's Disease Mechanisms and Treatments
- Polyomavirus and related diseases
- Dermatology and Skin Diseases
- SARS-CoV-2 and COVID-19 Research
- Neurological disorders and treatments
- Family Support in Illness
- Neurological and metabolic disorders
- Reproductive System and Pregnancy
- COVID-19 Clinical Research Studies
- Acute Lymphoblastic Leukemia research
- Sphingolipid Metabolism and Signaling
- Psoriasis: Treatment and Pathogenesis
- Digital Imaging for Blood Diseases
- Diverse Scientific Research Studies
- Urticaria and Related Conditions
- Health and Conflict Studies
- Bacterial Infections and Vaccines
- Medical Case Reports and Studies
- Antifungal resistance and susceptibility
Mazandaran University of Medical Sciences
2016-2025
Monash University
2024
The Royal Melbourne Hospital
2024
Box Hill Hospital
2024
Eastern Health
2024
Alfred Health
2024
Sina Hospital
2020-2024
Griffith University
2023
QIMR Berghofer Medical Research Institute
2023
University of Tasmania
2023
BACKGROUND: Most people with multiple sclerosis (MS) always crave for numerous sources of support to adjust this health condition; however, there is limited information available about their perceptions and experiences such sources. This study aimed explore MS patients’ regarding the reach adjustment. MATERIALS AND METHODS: qualitative was conducted in 2020–2022 through conventional content analysis approach. Thirteen patients MS, one patient companion, nurse, physician were purposively...
Introduction:Multiple Sclerosis (MS) is a debilitating neurological disorder that affects patients not only physically but also cognitively. Therefore, the aim of present study was to investigate effectiveness cognitive-behavioral therapy (CBT) on resilience, distress tolerance, and quality life in women with MS during acute phase Methods:This semi-experimental intervention design pre-test post-test, including control group. Thirty attending specialized clinic Bou Ali Sina Hospital Sari from...
Admittedly, little is known about the epidemiological signatures of familial multiple sclerosis (FMS) in different geographical regions Iran.To determine epidemiology and risk FMS incidence several provinces Iran with a ethnic population including, Fars, Tehran, Isfahan (Persians), Mazandaran (Mazanis), Kermanshah (Kurds), Chaharmahal Bakhtiari (Lors).This cross-sectional registry-based study was performed on nationwide MS registry (NMSRI) data collected from 2018 to 2021. This system,...
Background: The prognostic significance of non-disabling relapses in people with relapsing-remitting multiple sclerosis (RRMS) is unclear. Objective: To determine whether early predict disability accumulation RRMS. Methods: We redefined mild MSBase as ‘non-disabling’, and moderate or severe ‘disabling’. used mixed-effects Cox models to compare 90-day confirmed events exclusively within 2 years RRMS diagnosis those no relapses; any disabling relapses. Analyses were stratified by...
The COVID-19 pandemic raised concern amongst clinicians that disease-modifying therapies (DMT), particularly anti-CD20 monoclonal antibodies (mAb) and fingolimod, could worsen in people with multiple sclerosis (pwMS). This study aimed to examine DMT prescribing trends pre- post-pandemic onset.
Women with multiple sclerosis (MS) are at risk of disease reactivation in the early postpartum period. Ocrelizumab (OCR) is an anti-CD20 therapy highly effective reducing MS activity. Data remain limited regarding use disease-modifying therapies (DMTs), including OCR, and activity during peripregnancy periods.
Background: Mesenchymal stem cells (MSCs) are a potential therapy for various diseases. Here, the results of intrathecal injection MSCs in multiple sclerosis (MS) patients reported.Materials and methods: Four were enrolled study. Three male one was female. There three secondary-progressive MS relapsing-remitting patient. An amount 50–80 ml bone marrow collected from patients. MSC cultures each microbiological examination at change medium passage as well time sample injection. Then, injected...
There is limited evidence about the neurological manifestations of COVID-19 in infected patients. In this report, we describe three patients with ischemic stroke associated infection.
Introduction The incidence rate of MS is a valuable indicator the recent changes in risk this disease, and it widely implicated for health planning purposes. Objectives This study aims to determine over past eleven years Mazandaran province compare with other parts Iran world. Materials methods retrospective conducted by using registered data files patients their consent. yearly crude rates, age, sex-specific rates directly standardized population are calculated, temporal analyzed. Results...
BackgroundRegarding the high prevalence of multiple sclerosis (MS) and COVID-19 in Iran, a multicenter study Iranian MS patients with is carried out to address concerns this population.MethodsData on from nine provinces Iran were entered web-based registry system, between July 2020 March 2021. Among symptoms, dyspnea, altered mental status, or those resulting hospital admission considered severe.ResultsA total 397 eligible identified. In addition, 310 (78%) female. The mean age was 36.5 ±...
Abstract Background Information of Previous studies on the prevalence MS, including our study conducted 12 years ago, used to shape global map MS. According those results, Iran placed in medium-prevalence MS region world Atlas 2013.This aimed investigate Mazandaran province after and need for possible changes Methods We included all patients living 2018 this descriptive cross-sectional study. updated pre-existing registration questionnaires which demographic information medical data by...